 Headquarters of Intas Biopharmaceuticals (IBPL) | |
| Company type | Private |
|---|---|
| Industry | Pharmaceuticals Biopharmaceuticals |
| Founded | 1977 |
| Founder | Hasmukh Chudgar |
| Headquarters | Ahmedabad, Gujarat, India |
Area served | Worldwide |
Key people | Binish Chudgar (Vice Chairman and Joint MD) Nimish Chudgar (Joint MD and CEO) Urmish Chudgar (Joint MD) |
| Products | Pharmaceutical drugs, generic drugs, antiviral drugs, over-the-counter drugs, vaccines, |
| Revenue |  ₹20,079 crore (US$2.4 billion) (FY23)[1] |
 ₹2,422 crore (US$290 million) (FY23)[1] | |
Number of employees | 22093+ (2024) |
| Subsidiaries | Accord Healthcare |
| Website | www |
Intas Pharmaceuticals Limited is an Indian multinational pharmaceutical company headquartered in Ahmedabad.[2] It is a producer of generic therapeutic drugs and engaged in contract clinical research and manufacturing.[3] It has 22 manufacturing plants, 17 in India and the rest in Greece, United Kingdom and Mexico.[1] In the financial year 2019, 69% of the company's revenue came from international markets while 31% came from India.[4] Its market presence is in more than 100+ countries.
- ^ a b c "Intas Pharmaceuticals Limited". ICRA. Retrieved 4 December 2023.
- ^ Dandekar, Vikas; Barman, Arijit (7 October 2016). "Chudgars of Intas: A family that dreams big together". The Economic Times.
- ^ Shrivastava, Bhuma (29 September 2007). "Intas Pharma may offload 10% to raise Rs200 cr from market". mint. Retrieved 9 February 2023.
- ^ "Financials – Intas Pharmaceuticals Ltd". Intas Pharmaceuticals Ltd. Retrieved 1 January 2022.